|
![]() |
|
|
Aggrenox: profile and news
A Nation of Guinea Pigs Feb 28, 2006 ‘Nation of guinea pigs’? Mar 4, 2006 Harry Rush Jan 22, 2006 Most Extensive Thromboembolic Disease Clinical Trial Program ... Jan 29, 2006 Seniors pleasantly surprised by plan's low drug costs Jan 24, 2006 New advances in the care of stroke patients Oct 10, 2005 Strokes can be prevented if warning signs are heeded Jul 4, 2005 NICE Recommends Aggrenox (dipyridamol) as First Line Treatment for ... Jun 6, 2005 Ministrokes deserve more attention from patients, doctors Jun 26, 2005 Brain Attack A Look at Stroke Prevention and Treatment May 13, 2005 Stroke units offer support for patients, families Feb 28, 2005 Other information Indication For as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina Pharmacology Dipyridamole, a non-nitrate coronary vasodilator that also inhibits platelet aggregation, is combined with other anticoagulant drugs, such as warfarin, to prevent thrombosis in patients with valvular or vascular disorders. Dipyridamole is also used in myocardial perfusion imaging, as an antiplatelet agent, and in combination with aspirin for stroke prophylaxis. Mechanism Of Action Dipyridamole likely inhibits both adenosine deaminase and phosphodiesterase, preventing the degradation of cAMP, an inhibitor of platelet function. This elevation in cAMP blocks the release of arachidonic acid from membrane phospholipids and reduces thromboxane A2 activity. Dipyridamole also directly stimulates the release of prostacyclin, which induces adenylate cyclase activity, thereby raising the intraplatelet concentration of cAMP and further inhibiting platelet aggregation. Drug Category Vasodilator Agents; Vasodilator Agents; ATC:B01AC07 Brand Names/Synonyms Aggrenox; Agilease; Anginal; Apo-Dipyridamole Fc; Apo-Dipyridamole Sc; Apricor; Cardioflux; Cardoxil; Cardoxin; Chilcolan; Cleridium; Cleridium 150; Coribon; Coridil; Coronarine; Corosan; Coroxin; Curantyl; Dipiridamol; Dipyridamine; Dipyridamol; Dipyridamole; Dipyridamole, Pharma; Dipyridan; Dipyudamine; Dypyridamol; Gulliostin; Iv Persantine; Justpertin; Kurantil; Natyl; Novo-Dipiradol; Peridamol; Permiltin; Persantin; Persantine; Piroan; Prandiol; Prandiol 75; Protangix; RA 8; RA-8; Stenocardil; Stenocardiol; Stimolcardio; Usaf Ge-12 Dosage Forms tablets Absorption 70% Interactions Interactions for Dipyridamole: No pharmacokinetic drug-drug interaction studies were conducted with PERSANTINE® (dipyridamole USP) Tablets. The following information was obtained from the literature. Adenosine: Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine. Adjustment of adenosine dosage may be necessary. Cholinesterase Inhibitors: Dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia gravis. Chemical IUPAC Name 2-[[3-[bis(2-hydroxyethyl)amino]-5,10-bis(1-piperidyl)-2,4,7,9-tetrazabicyclo[4.4.0]deca-2,4,7,9,11-pentaen-8-yl]-(2-hydroxyethyl)amino]ethanol Chemical Formula C24H40N8O4 Half Life 40 minutes Drug Type Approved Drug # Accession No APRD00360 CAS Registry Number 58-32-2 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |